The capital raise has secured more than $720,000 in investment from about 140 people. It needs more than $1.2 million to reach the $2 million mark by the time it closes on Thursday, though it has already surpassed its $700,000 minimum.
Admittedly, that’s a tough high target to reach in such a short timeframe. But the folks behind Veriphi are resolute in their belief that their solution for catching medication errors can save lives.
Veriphi had its first successful Snowball Effect capital raise in 2016, and since that time has expanded its team of in-house engineers and technicians, refined the technology for commercial manufacture, and commenced hospital trials. It is now on the cusp of its first commercial sales.